LENTI-VEX

Serial Number 97403222
606

Registration Progress

Application Filed
May 10, 2022
Under Examination
Dec 13, 2022
Approved for Publication
Oct 18, 2022
Published for Opposition
Oct 18, 2022
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: LENTI-VEX
Previous Owner: Castle Creek Biosciences, LLC
Classes: 042

Trademark Image

LENTI-VEX

Basic Information

Serial Number
97403222
Filing Date
May 10, 2022
Published for Opposition
October 18, 2022
Abandonment Date
July 17, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 17, 2023
Classes
042

Rights Holder

Castle Creek Biosciences, LLC

16
Address
405 Eagleview Blvd.
Exton, PA 19341

Ownership History

Castle Creek Biosciences, LLC

Original Applicant
16
Exton, PA

Castle Creek Biosciences, LLC

Owner at Publication
16
Exton, PA

Legal Representation

Attorney
Edward F. Behm, Jr.

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

14 events
Date Code Type Description Documents
Jul 17, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 17, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 13, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 18, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 18, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 13, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 8, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 31, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 31, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 31, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 31, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 13, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Testing, inspection, research, and development of pharmaceutical preparations for ex vivo cell therapy, ex vivo gene therapy and gene editing; medical and scientific research in the fields of ex vivo cell therapy, ex vivo gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services

Classification

International Classes
042